| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.005 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.005 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.006 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.007 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |